Nehas
ImClone Systems Incorporated (ImClone) is a "biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer." ImClone Co. was founded in 1984. In 1986, the company opened its laboratories at 180 Varick Street in New York City. The Company focused on seclusion-based analysis and transmittable disease serums. This focus brought about two "FDA approved diagnostics" and many vaccine research programs. As time went on, the Company's focus moved from diagnostics and transmittable disease to the area of oncology.
I decided to invest in this company because it is a company that many people are not familiar with. The research that this company performs may one day find a cure for cancer and many other horrible diseases that have sprung up in today's world.
ImClone has produced a product called ERBITUX which is an antibody approved by the United States Food and Drug Administration. Their new product is used......
View the rest of this paper...
Approximate Word Count: 358
Approximate Pages: 2 (250 words per double-spaced page)
Why should you join Frat Files?
- - It's safe, secure, and private.
- - Instant access to over 100,000 papers. New papers are added hourly.
- - Fast and reliable customer support.
Similar Essays
-
Nehas
nehas. ImClone Systems Incorporated (ImClone) is a "biopharmaceutical company
that develops a portfolio of targeted biologic treatments ...
Frat Files
Members
Information
